Who
Peter Kuan-How Lin
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Apollomics.
In numbers
- Trades disclosed
- 26
- Buys
- 1
- Sells
- 0
- Bought
- $800K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Mar 2026
- Last trade
- 15 Sep 2026
- Last filed
- 24 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 24 Sep 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 15 Sep 2026filed 24 Sep 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code F | $82K3,416 at $24.02 | filing |
| 15 Sep 2026filed 24 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 15 Sep 2026filed 24 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 15 Sep 2026filed 24 Sep 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 15 Sep 2026filed 24 Sep 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code F | $82K3,416 at $24.02 | filing |
| 15 Sep 2026filed 17 Sep 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code F | $82K3,416 at $24.02 | filing |
| 15 Sep 2026filed 17 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code F | $82K3,416 at $24.02 | filing |
| 14 Sep 2026filed 24 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 14 Sep 2026filed 24 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 14 Sep 2026filed 17 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 14 Sep 2026filed 17 Sep 2026 | APLM Apollomicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 14 Aug 2026filed 17 Aug 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Bought | $400K26,667 at $15.00 | filing |
| 14 Aug 2026filed 17 Aug 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Bought | $400K26,667 at $15.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | APLM ApollomicsBiotechnology | SEC FORM 4 Code F | $50K3,588 at $13.85 | filing |
News
No headline names them, or the companies they trade most, lately.